Fung Ariane, Foong-Reichert Ai-Leng, Houle Sherilyn K D, Grindrod Kelly A
, BSc, PharmD, was, at the time of the study, a pharmacy student at the University of Waterloo School of Pharmacy, Kitchener, Ontario. She will be starting a hospital pharmacy residency in mid-2022.
, BSc, PharmD, is a candidate in the PhD program, University of Waterloo School of Pharmacy, Kitchener, Ontario.
Can J Hosp Pharm. 2022 Spring;75(2):97-103. doi: 10.4212/cjhp.v75i2.3123. Epub 2022 Apr 4.
Past research on disciplinary action by pharmacist regulatory bodies has shown that most cases concern community pharmacists, with few occurring in a hospital setting.
To investigate how discipline-related issues involving pharmacists are dealt with by hospital pharmacy departments in Canada.
Hospital pharmacy directors and managers from small, medium, and large hospitals across Canada were invited to participate in semi-structured telephone interviews. The interview questions focused on the discipline process in participants' organizations, the situations when reporting to the regulatory body is deemed to be warranted, possible penalties, and recommendations for improving the regulatory body or organizational discipline process.
Ten participants, from British Columbia, Saskatchewan, Ontario, New Brunswick, Prince Edward Island, and Newfoundland and Labrador, agreed to be interviewed. Five key themes emerged as contributing to lower rates of hospital pharmacist discipline cases being escalated to the regulatory college level: robust organizational discipline processes independent from the regulatory college, a practice environment promoting competence, union representation, preference for a remedial approach to discipline, and lack of clarity about when to report to the regulatory authority.
This study identified a number of reasons why discipline of hospital pharmacists by a regulatory body may be less prevalent than discipline relating to community pharmacists. The main reasons may be lack of clarity about when to report a case to the regulator and a lack of transparency, given that many cases are handled internally within hospitals. Environmental supports for competence and employee protections (e.g., through a union) may also reduce discipline cases.
过去关于药剂师监管机构纪律处分的研究表明,大多数案例涉及社区药剂师,很少发生在医院环境中。
调查加拿大医院药房部门如何处理涉及药剂师的纪律相关问题。
邀请加拿大各地小型、中型和大型医院的药房主任和经理参加半结构化电话访谈。访谈问题集中在参与者所在组织的纪律处分程序、认为有必要向监管机构报告的情况、可能的处罚以及对改进监管机构或组织纪律处分程序的建议。
来自不列颠哥伦比亚省、萨斯喀彻温省、安大略省、新不伦瑞克省、爱德华王子岛省以及纽芬兰和拉布拉多省的10名参与者同意接受访谈。出现了五个关键主题,这些主题导致医院药剂师纪律处分案件升级到监管学院层面的比率较低:独立于监管学院的强大组织纪律程序、促进能力的实践环境、工会代表、倾向于采取补救性纪律处分方法以及何时向监管机构报告缺乏明确性。
本研究确定了监管机构对医院药剂师进行纪律处分可能不如对社区药剂师纪律处分普遍的一些原因。主要原因可能是对于何时向监管机构报告案件缺乏明确性以及缺乏透明度,因为许多案件是在医院内部处理的。对能力的环境支持和员工保护(例如通过工会)也可能减少纪律处分案件。